COVID & Blood Cancer

July 1, 2021 Run Time: 42 min

The Cancer Support Community’s VP of Education & Outreach, Claire Saxton, MBA, talks with multiple myeloma specialist Saad Z. Usmani, MD, MBA, FACP, about the effects of COVID-19 on blood cancer patients. Dr. Usmani is the Director of Clinical Research in Hematologic Malignancies in the Department of Hematologic Oncology & Blood Disorders at the Levine Cancer Institute in Charlotte, North Carolina. They discuss how COVID-19 has impacted blood cancer treatment and common concerns about the COVID-19 vaccine from blood cancer patients, including multiple myeloma.

Library

You can find this video and more information on these pages:

Read

Myelodysplastic Syndromes (MDS)

Learn about myelodysplastic syndromes, including risk factors, signs and symptoms, diagnosis, treatment planning, and...

Read

Multiple Myeloma

Multiple Myeloma (MM) is a blood cancer that starts in the plasma cells of bone marrow. This is the spongy material in...

COVID & Blood Cancer

You can find this video and more information on these pages:

Myelodysplastic Syndromes (MDS)

Multiple Myeloma

More From Your Library

Shared Decision Making for DLBCL

What You Need to Know about the GI Side Effects of NSCLC Treatment

Meet the Navigators: Madison